Parsons (PSN) Financials

Parsons logo
$51.16 +0.52 (+1.03%)
As of 10:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Parsons

Annual Income Statements for Parsons

This table shows Parsons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
97 222 121 99 64 97 161 235 241
Consolidated Net Income / (Loss)
112 239 137 119 89 127 208 291 309
Net Income / (Loss) Continuing Operations
112 239 137 119 89 127 208 291 309
Total Pre-Tax Income
133 260 67 161 113 166 264 368 383
Total Operating Income
151 205 92 178 132 186 288 428 418
Total Gross Profit
617 766 832 877 853 947 1,206 1,406 1,432
Total Revenue
3,017 3,561 3,955 3,919 3,661 4,195 5,443 6,751 6,364
Operating Revenue
3,017 3,561 3,955 3,919 3,661 4,195 5,443 6,751 6,364
Total Cost of Revenue
2,400 2,795 3,123 3,042 2,808 3,249 4,237 5,344 4,933
Operating Cost of Revenue
2,400 2,795 3,123 3,042 2,808 3,249 4,237 5,344 4,933
Total Operating Expenses
466 560 740 699 720 761 918 978 1,013
Selling, General & Admin Expense
506 597 781 729 757 777 870 955 1,016
Other Operating Expenses / (Income)
-40 -37 -42 -30 -37 -16 48 23 -2.58
Total Other Income / (Expense), net
-18 55 -25 -16 -20 -19 -24 -60 -36
Interest Expense
16 21 24 21 18 23 31 52 51
Interest & Investment Income
2.47 2.71 1.30 0.79 0.40 0.97 2.19 11 6.88
Other Income / (Expense), net
-4.37 73 -2.39 3.77 -2.56 2.78 5.00 -20 8.86
Income Tax Expense
21 20 -70 42 24 40 56 77 74
Net Income / (Loss) Attributable to Noncontrolling Interest
14 17 17 20 25 30 47 56 68
Basic Earnings per Share
$1.16 $2.78 $1.30 $0.98 $0.62 $0.93 $1.53 $2.21 $2.26
Weighted Average Basic Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Diluted Earnings per Share
$1.16 $2.78 $1.30 $0.97 $0.59 $0.87 $1.42 $2.12 $2.20
Weighted Average Diluted Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Weighted Average Basic & Diluted Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M

Quarterly Income Statements for Parsons

This table shows Parsons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
40 69 72 201 66 55 64 56 53 -15 54
Consolidated Net Income / (Loss)
55 81 86 216 82 70 82 75 65 -0.47 67
Net Income / (Loss) Continuing Operations
55 81 86 216 82 70 82 75 65 -0.47 67
Total Pre-Tax Income
68 103 108 281 101 89 98 95 81 3.76 88
Total Operating Income
102 111 115 100 109 96 108 105 96 1.30 104
Total Gross Profit
325 352 360 370 354 348 360 369 357 295 382
Total Revenue
1,536 1,670 1,810 1,734 1,554 1,584 1,622 1,604 1,491 1,576 1,651
Operating Revenue
1,536 1,670 1,810 1,734 1,554 1,584 1,622 1,604 1,491 1,576 1,651
Total Cost of Revenue
1,211 1,319 1,450 1,365 1,200 1,236 1,262 1,234 1,134 1,281 1,268
Operating Cost of Revenue
1,211 1,319 1,450 1,365 1,200 1,236 1,262 1,234 1,134 1,281 1,268
Total Operating Expenses
223 240 245 247 245 253 252 264 262 294 278
Selling, General & Admin Expense
221 223 246 265 244 252 260 260 268 260 285
Other Operating Expenses / (Income)
2.06 17 -0.87 - 0.69 0.64 -8.27 4.35 -6.16 34 -7.24
Total Other Income / (Expense), net
-34 -8.29 -6.88 158 -8.47 -6.48 -10 -10 -14 2.46 -16
Interest Expense
13 13 13 -180 12 13 14 13 16 16 16
Interest & Investment Income
1.15 3.83 4.23 -21 2.14 1.07 1.84 1.83 1.81 0.57 0.86
Other Income / (Expense), net
-22 0.90 1.92 -1.40 1.64 5.02 1.57 0.64 -0.19 18 -0.53
Income Tax Expense
13 22 23 64 19 19 16 20 16 4.22 20
Net Income / (Loss) Attributable to Noncontrolling Interest
15 12 14 15 16 15 18 19 12 15 13
Basic Earnings per Share
$0.37 $0.65 $0.68 $1.89 $0.62 $0.52 $0.60 $0.52 $0.49 ($0.14) $0.51
Weighted Average Basic Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M
Diluted Earnings per Share
$0.37 $0.63 $0.65 $1.85 $0.60 $0.50 $0.59 $0.51 $0.49 ($0.14) $0.51
Weighted Average Diluted Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M
Weighted Average Basic & Diluted Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M

Annual Cash Flow Statements for Parsons

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
53 -165 -86 292 -143 -81 10 181 13
Net Cash From Operating Activities
265 285 220 289 206 238 408 524 478
Net Cash From Continuing Operating Activities
265 285 220 289 206 238 408 524 478
Net Income / (Loss) Continuing Operations
112 239 137 119 89 127 208 291 309
Consolidated Net Income / (Loss)
112 239 137 119 89 127 208 291 309
Depreciation Expense
35 70 126 128 144 121 120 99 116
Amortization Expense
-6.78 -6.53 0.97 5.19 2.82 3.03 2.84 7.80 5.06
Non-Cash Adjustments To Reconcile Net Income
59 -364 27 60 65 60 154 237 22
Changes in Operating Assets and Liabilities, net
66 346 -71 -23 -95 -72 -77 -112 26
Net Cash From Investing Activities
-53 -503 -571 -346 -241 -417 -376 -557 -256
Net Cash From Continuing Investing Activities
-53 -503 -571 -346 -256 -417 -376 -557 -256
Purchase of Property, Plant & Equipment
-28 -29 -68 -34 -21 -31 -40 -49 -68
Acquisitions
-29 -486 -519 -314 -237 -397 -342 -563 -229
Sale of Property, Plant & Equipment
2.25 0.44 3.79 1.55 1.33 0.77 0.55 0.18 0.84
Divestitures
- - 0.00 0.00 0.00 0.00 0.38 0.00 0.00
Sale and/or Maturity of Investments
1.97 11 12 0.05 0.77 9.44 5.02 55 40
Net Cash From Financing Activities
-160 55 266 348 -107 100 -22 219 -214
Net Cash From Continuing Financing Activities
-160 55 266 348 -102 100 -22 219 -214
Repayment of Debt
-1.95 -81 -777 -223 -50 -1,171 -621 -172 -596
Repurchase of Preferred Equity
- - - - - 0.00 0.00 -498 -113
Repurchase of Common Equity
- - -6.27 0.00 -22 -33 -11 -25 -125
Payment of Dividends
-51 -19 -94 -5.82 -38 -24 -12 -29 -63
Issuance of Debt
0.00 260 597 613 0.00 1,320 621 953 694
Issuance of Common Equity
7.48 21 547 20 7.31 16 8.93 10 10
Other Financing Activities, net
-114 -126 0.00 -56 0.00 -7.04 -7.30 -20 -20
Effect of Exchange Rate Changes
1.24 -1.70 -1.29 0.82 -1.50 -1.77 0.55 -5.04 4.14
Cash Interest Paid
13 17 23 14 15 21 30 34 44

Quarterly Cash Flow Statements for Parsons

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
150 105 30 -105 -184 142 11 44 -182 -18 31
Net Cash From Operating Activities
-63 161 299 127 -12 160 163 168 -3.70 58 269
Net Cash From Continuing Operating Activities
-63 161 299 127 -12 160 163 168 -3.70 58 269
Net Income / (Loss) Continuing Operations
55 81 86 216 82 70 82 75 65 -0.47 67
Consolidated Net Income / (Loss)
55 81 86 216 82 70 82 75 65 -0.47 67
Depreciation Expense
25 24 25 26 27 29 30 31 36 37 34
Amortization Expense
4.10 1.23 1.24 1.24 1.22 1.39 1.22 1.22 1.21 1.23 1.22
Non-Cash Adjustments To Reconcile Net Income
53 11 60 -90 -36 22 45 -8.11 -62 -10 141
Changes in Operating Assets and Liabilities, net
-200 44 128 -27 -86 37 5.04 69 -44 30 25
Net Cash From Investing Activities
-46 -43 -256 -212 -62 -103 -24 -67 -365 -22 -40
Net Cash From Continuing Investing Activities
-46 -43 -256 -212 -62 -103 -24 -67 -365 -22 -40
Purchase of Property, Plant & Equipment
-9.44 -9.26 -12 -19 -13 -9.44 -13 -32 -15 -16 -18
Acquisitions
-36 -34 -244 -248 -48 -105 -27 -48 -357 -30 -22
Sale and/or Maturity of Investments
- - - 55 0.00 - 16 12 7.54 0.04 -0.04
Net Cash From Financing Activities
260 -12 -13 -15 -111 82 -127 -58 186 -53 -198
Net Cash From Continuing Financing Activities
260 -12 -13 -15 -111 82 -127 -58 186 -53 -198
Repayment of Debt
-172 -0.24 - 800 -146 -450 - - -76 -145 -232
Repurchase of Common Equity
0.00 -10 - -15 -25 -15 -25 -60 -35 -15 -60
Payment of Dividends
-11 -3.99 -14 -0.19 -42 -3.05 -18 -0.45 -34 -2.95 -19
Issuance of Debt
953 - - -800 146 548 - - 350 105 114
Issuance of Common Equity
0.00 3.82 0.96 5.33 0.26 4.86 1.18 4.16 0.81 5.13 0.27
Other Financing Activities, net
-15 -2.03 -0.29 -3.33 -16 -2.57 -0.75 -1.36 -20 -0.23 -0.48
Effect of Exchange Rate Changes
-0.40 -0.24 0.33 -4.72 0.52 2.75 -0.35 1.23 -0.67 -0.50 0.02

Annual Balance Sheets for Parsons

This table presents Parsons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,613 3,450 3,938 3,831 4,198 4,804 5,488 5,770
Total Current Assets
1,489 1,526 1,843 1,632 1,720 2,138 2,462 2,684
Cash & Equivalents
280 183 484 343 263 273 454 466
Accounts Receivable
623 671 699 598 717 916 1,100 1,124
Prepaid Expenses
69 84 81 111 106 191 167 177
Other Current Assets
515 575 577 579 634 758 742 916
Other Current Nonoperating Assets
- - - - - - - 0.00
Plant, Property, & Equipment, net
92 123 121 104 96 99 112 151
Total Noncurrent Assets
1,032 1,801 1,974 2,094 2,382 2,568 2,914 2,935
Long-Term Investments
64 69 69 111 107 128 139 149
Goodwill
737 1,047 1,262 1,413 1,662 1,793 2,083 2,187
Intangible Assets
180 260 246 208 254 276 350 326
Noncurrent Deferred & Refundable Income Taxes
5.68 130 130 134 138 140 133 88
Other Noncurrent Operating Assets
46 295 266 229 221 231 209 186
Total Liabilities & Shareholders' Equity
2,613 3,450 3,938 3,831 4,198 4,804 5,488 5,770
Total Liabilities
1,657 1,790 2,076 1,894 2,102 2,427 2,953 3,002
Total Current Liabilities
1,006 1,144 1,187 1,031 1,108 1,411 1,916 1,532
Accounts Payable
226 217 226 196 201 243 208 251
Accrued Expenses
560 640 651 599 630 801 894 884
Current Deferred Revenue
209 231 202 172 213 301 290 340
Current Deferred & Payable Income Tax Liabilities
12 7.23 4.98 7.84 4.29 6.98 7.70 11
Other Current Liabilities
0.00 50 54 56 - 59 53 45
Other Current Nonoperating Liabilities
- - - - - - - 0.00
Total Noncurrent Liabilities
651 645 889 863 994 1,016 1,038 1,470
Long-Term Debt
429 249 540 592 744 746 784 1,238
Capital Lease Obligations
46 - - 149 111 118 114 94
Noncurrent Deferred & Payable Income Tax Liabilities
6.24 9.62 12 11 12 9.78 11 12
Other Noncurrent Operating Liabilities
170 386 337 111 127 143 128 126
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-921 1,661 1,861 1,937 2,096 2,377 2,534 2,768
Total Preferred & Common Equity
-968 1,630 1,814 1,901 2,044 2,287 2,416 2,642
Total Common Equity
-968 1,630 1,814 1,901 2,044 2,287 2,416 2,642
Common Stock
0.00 2,796 2,848 2,831 2,863 2,926 2,831 2,794
Retained Earnings
12 -218 -121 -54 43 204 427 661
Treasury Stock
-957 -934 -899 -867 -845 -827 -815 -793
Accumulated Other Comprehensive Income / (Loss)
-23 -14 -14 -9.57 -18 -15 -27 -21
Noncontrolling Interest
46 31 48 36 52 90 118 126

Quarterly Balance Sheets for Parsons

This table presents Parsons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
4,508 4,733 5,098 5,239 5,443 5,449 5,721 5,737 6,012 6,107 5,985
Total Current Assets
1,980 2,016 2,427 2,574 2,555 2,401 2,594 2,649 2,594 2,720 2,579
Cash & Equivalents
179 205 423 528 559 270 411 423 284 266 297
Accounts Receivable
949 907 1,023 1,043 1,035 1,125 1,168 1,224 1,097 1,146 1,108
Prepaid Expenses
140 147 213 199 171 184 178 180 192 228 201
Other Current Assets
712 757 768 804 790 823 836 822 1,022 1,062 952
Other Current Nonoperating Assets
- - - - - - - - - 17 21
Plant, Property, & Equipment, net
95 99 98 98 101 122 123 126 155 160 168
Total Noncurrent Assets
2,432 2,618 2,573 2,567 2,787 2,926 3,005 2,962 3,263 3,227 3,238
Long-Term Investments
119 165 145 157 195 142 151 156 162 153 175
Goodwill
1,693 1,797 1,791 1,791 1,931 2,107 2,162 2,163 2,424 2,421 2,422
Intangible Assets
240 282 262 248 308 340 361 339 408 384 363
Noncurrent Deferred & Refundable Income Taxes
145 149 158 163 164 132 134 107 60 61 60
Other Noncurrent Operating Assets
235 225 217 208 190 205 196 196 209 207 219
Total Liabilities & Shareholders' Equity
4,508 4,733 5,098 5,239 5,443 5,449 5,721 5,737 6,012 6,107 5,985
Total Liabilities
2,317 2,485 2,855 2,919 3,029 2,903 3,100 3,072 3,258 3,359 3,237
Total Current Liabilities
1,295 1,394 1,354 1,427 1,650 1,865 1,608 1,588 1,480 1,637 1,617
Short-Term Debt
57 57 55 53 115 435 85 0.00 43 40 39
Accounts Payable
237 266 274 253 300 289 288 271 233 247 243
Accrued Expenses
694 772 739 822 877 784 848 912 832 941 969
Current Deferred Revenue
292 277 283 298 - 298 320 344 360 347 308
Current Deferred & Payable Income Tax Liabilities
15 22 2.37 1.04 4.56 7.69 13 11 13 2.10 0.26
Other Current Nonoperating Liabilities
- - - - - - - - - 61 57
Total Noncurrent Liabilities
1,022 1,091 1,502 1,492 1,379 1,038 1,492 1,484 1,778 1,722 1,620
Long-Term Debt
745 820 1,246 1,247 1,133 785 1,236 1,237 1,513 1,474 1,357
Capital Lease Obligations
129 119 107 98 98 108 100 98 121 120 133
Noncurrent Deferred & Payable Income Tax Liabilities
20 20 9.76 9.79 28 11 19 18 12 10 10
Other Noncurrent Operating Liabilities
128 131 139 137 121 133 137 132 132 118 119
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,191 2,248 2,243 2,320 2,414 2,546 2,622 2,665 2,754 2,748 2,748
Total Preferred & Common Equity
2,119 2,173 2,150 2,219 2,312 2,454 2,516 2,558 2,650 2,631 2,638
Total Common Equity
2,119 2,173 2,150 2,219 2,312 2,454 2,516 2,558 2,650 2,631 2,638
Common Stock
2,868 2,876 2,907 2,909 2,929 2,807 2,807 2,792 2,756 2,757 2,709
Retained Earnings
112 159 87 156 227 488 542 606 710 695 749
Treasury Stock
-845 -845 -827 -827 -827 -815 -815 -815 -793 -793 -793
Accumulated Other Comprehensive Income / (Loss)
-15 -17 -17 -19 -16 -26 -18 -24 -23 -27 -27
Noncontrolling Interest
71 75 93 101 102 92 106 107 105 116 111

Annual Metrics And Ratios for Parsons

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 18.01% 11.07% -0.91% -6.59% 14.60% 29.74% 24.03% -5.72%
EBITDA Growth
0.00% 95.29% -36.61% 45.49% -12.02% 12.66% 33.40% 28.12% 6.53%
EBIT Growth
0.00% 89.93% -67.74% 102.50% -28.47% 45.08% 55.68% 45.27% 4.69%
NOPAT Growth
0.00% 49.50% -0.63% -30.22% -20.12% 35.10% 60.61% 49.05% -0.25%
Net Income Growth
0.00% 114.67% -42.73% -13.28% -25.20% 42.28% 64.28% 39.80% 6.26%
EPS Growth
0.00% 139.66% -53.24% -25.38% -39.18% 47.46% 63.22% 49.30% 3.77%
Operating Cash Flow Growth
0.00% 7.40% -22.62% 31.29% -28.91% 15.54% 71.64% 28.43% -8.64%
Free Cash Flow Firm Growth
0.00% 0.00% 58.43% 68.31% -89.23% -23.23% 110.22% -549.69% 224.12%
Invested Capital Growth
0.00% 0.00% 51.63% 15.13% 17.31% 18.75% 7.53% 16.38% 5.46%
Revenue Q/Q Growth
0.00% 0.00% 2.82% -1.83% -0.37% 3.77% 7.74% 3.69% -2.01%
EBITDA Q/Q Growth
0.00% 0.00% 6.38% 7.69% 1.73% 3.00% 5.41% 2.13% -1.09%
EBIT Q/Q Growth
0.00% 0.00% 1.56% 12.36% 1.63% 9.59% 6.84% 4.32% -2.49%
NOPAT Q/Q Growth
0.00% 0.00% 1.07% 3.16% 11.07% 2.64% 8.52% 0.38% 1.33%
Net Income Q/Q Growth
0.00% 0.00% 6.26% 4.02% 11.59% 0.16% 11.66% 119.78% 1.79%
EPS Q/Q Growth
0.00% 0.00% 4.00% 4.30% 9.26% -2.25% 11.81% 221.21% 1.85%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -30.18% 42.41% -29.46% -0.29% 32.92% -10.80% 9.31%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -230.99% 26.52% 25.64% 130.88% -161.99% 297.50%
Invested Capital Q/Q Growth
0.00% 0.00% 0.94% 13.65% 7.62% 2.57% -1.23% 9.87% 1.88%
Profitability Metrics
- - - - - - - - -
Gross Margin
20.45% 21.50% 21.03% 22.37% 23.30% 22.57% 22.16% 20.83% 22.49%
EBITDA Margin
5.79% 9.58% 5.47% 8.03% 7.56% 7.44% 7.65% 7.90% 8.62%
Operating Margin
5.00% 5.76% 2.33% 4.54% 3.62% 4.43% 5.30% 6.34% 6.57%
EBIT Margin
4.85% 7.81% 2.27% 4.63% 3.55% 4.49% 5.39% 6.31% 6.71%
Profit (Net Income) Margin
3.70% 6.72% 3.47% 3.03% 2.43% 3.02% 3.82% 4.31% 4.85%
Tax Burden Percent
83.86% 92.16% 203.93% 73.68% 79.01% 76.14% 78.74% 79.06% 80.75%
Interest Burden Percent
90.89% 93.48% 74.99% 88.89% 86.68% 88.21% 90.01% 86.27% 89.59%
Effective Tax Rate
16.14% 7.84% -103.93% 26.33% 20.99% 23.86% 21.26% 20.94% 19.25%
Return on Invested Capital (ROIC)
0.00% 34.81% 13.75% 7.40% 5.08% 5.81% 8.29% 11.02% 9.95%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 112.25% -73.70% -118.69% -4.72% 2.25% 4.49% 3.26% 6.08%
Return on Net Nonoperating Assets (RNNOA)
0.00% 15.33% -3.26% -0.65% -0.40% 0.46% 1.01% 0.82% 1.71%
Return on Equity (ROE)
0.00% 50.13% 10.48% 6.75% 4.68% 6.28% 9.30% 11.84% 11.65%
Cash Return on Invested Capital (CROIC)
0.00% -165.19% -27.29% -6.67% -10.85% -11.33% 1.03% -4.12% 4.63%
Operating Return on Assets (OROA)
0.00% 10.64% 2.96% 4.92% 3.34% 4.69% 6.52% 8.28% 7.58%
Return on Assets (ROA)
0.00% 9.16% 4.52% 3.22% 2.29% 3.15% 4.62% 5.65% 5.49%
Return on Common Equity (ROCE)
0.00% -50.78% 2.65% 6.60% 4.58% 6.14% 9.00% 11.34% 11.11%
Return on Equity Simple (ROE_SIMPLE)
0.00% -24.75% 8.41% 6.56% 4.68% 6.19% 9.09% 12.03% 0.00%
Net Operating Profit after Tax (NOPAT)
126 189 188 131 105 141 227 338 338
NOPAT Margin
4.19% 5.31% 4.75% 3.34% 2.86% 3.37% 4.17% 5.01% 5.30%
Net Nonoperating Expense Percent (NNEP)
0.00% -77.45% 87.44% 126.09% 9.80% 3.57% 3.80% 7.75% 3.86%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 4.70% 7.01% 8.69% 8.23%
Cost of Revenue to Revenue
79.55% 78.50% 78.97% 77.63% 76.70% 77.43% 77.84% 79.17% 77.51%
SG&A Expenses to Revenue
16.78% 16.78% 19.76% 18.60% 20.69% 18.53% 15.98% 14.15% 15.96%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.45% 15.74% 18.70% 17.84% 19.68% 18.14% 16.86% 14.15% 15.92%
Earnings before Interest and Taxes (EBIT)
146 278 90 182 130 188 293 426 427
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
175 341 216 315 277 312 416 533 548
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.51 2.02 1.81 2.34 2.88 4.05 2.49
Price to Tangible Book Value (P/TBV)
0.00 0.00 12.70 11.99 12.28 37.52 30.04 0.00 50.82
Price to Revenue (P/Rev)
0.17 0.14 1.04 0.94 0.94 1.14 1.21 1.45 1.03
Price to Earnings (P/E)
5.14 2.25 34.00 37.22 53.70 49.52 40.82 41.68 27.29
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
19.47% 44.47% 2.94% 2.69% 1.86% 2.02% 2.45% 2.40% 3.66%
Enterprise Value to Invested Capital (EV/IC)
0.00 2.35 2.50 1.98 1.69 2.04 2.51 3.23 2.13
Enterprise Value to Revenue (EV/Rev)
0.00 0.72 1.04 0.96 1.03 1.28 1.31 1.58 1.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 7.48 19.02 11.91 13.59 17.26 17.13 20.04 13.53
Enterprise Value to EBIT (EV/EBIT)
0.00 9.19 45.88 20.65 28.98 28.57 24.30 25.07 17.39
Enterprise Value to NOPAT (EV/NOPAT)
0.00 13.51 21.91 28.62 35.97 38.08 31.40 31.57 21.99
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 8.97 18.68 12.96 18.31 22.67 17.49 20.40 15.52
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 253.23 0.00 47.24
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.50 0.15 0.32 0.38 0.44 0.36 0.54 0.48
Long-Term Debt to Equity
0.00 0.50 0.15 0.29 0.38 0.41 0.36 0.35 0.48
Financial Leverage
0.00 0.14 0.04 0.01 0.08 0.21 0.23 0.25 0.28
Leverage Ratio
0.00 2.74 2.32 2.10 2.05 1.99 2.01 2.10 2.12
Compound Leverage Factor
0.00 2.56 1.74 1.86 1.77 1.76 1.81 1.81 1.90
Debt to Total Capital
0.00% 33.22% 13.05% 24.07% 27.66% 30.37% 26.65% 34.95% 32.49%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 2.04% 0.00% 1.96% 0.00% 11.89% 0.00%
Long-Term Debt to Total Capital
0.00% 33.22% 13.05% 22.03% 27.66% 28.41% 26.65% 23.06% 32.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 134.42% 1.62% 1.94% 1.36% 1.74% 2.76% 3.03% 3.07%
Common Equity to Total Capital
0.00% -67.64% 85.33% 73.99% 70.98% 67.89% 70.59% 62.02% 64.45%
Debt to EBITDA
0.00 1.39 1.15 1.87 2.68 2.93 2.07 2.55 2.43
Net Debt to EBITDA
0.00 0.38 -0.07 0.11 1.03 1.74 1.11 1.44 1.31
Long-Term Debt to EBITDA
0.00 1.39 1.15 1.72 2.68 2.74 2.07 1.69 2.43
Debt to NOPAT
0.00 2.52 1.33 4.50 7.08 6.47 3.80 4.02 3.95
Net Debt to NOPAT
0.00 0.69 -0.08 0.26 2.74 3.85 2.04 2.27 2.12
Long-Term Debt to NOPAT
0.00 2.52 1.33 4.12 7.08 6.05 3.80 2.65 3.95
Altman Z-Score
0.00 2.12 2.65 2.36 2.33 2.70 3.20 3.70 3.06
Noncontrolling Interest Sharing Ratio
0.00% 201.29% 74.68% 2.23% 2.21% 2.20% 3.17% 4.23% 4.60%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.48 1.33 1.55 1.58 1.55 1.52 1.29 1.75
Quick Ratio
0.00 0.90 0.75 1.00 0.91 0.88 0.84 0.81 1.04
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -897 -373 -118 -223 -275 28 -127 157
Operating Cash Flow to CapEx
1,031.68% 986.80% 345.16% 890.00% 1,039.51% 796.48% 1,023.08% 1,067.84% 712.64%
Free Cash Flow to Firm to Interest Expense
0.00 -43.02 -15.71 -5.64 -12.63 -11.88 0.89 -1.81 3.06
Operating Cash Flow to Interest Expense
16.78 13.66 9.28 13.80 11.62 10.24 12.94 7.49 9.32
Operating Cash Flow Less CapEx to Interest Expense
15.15 12.27 6.59 12.25 10.50 8.96 11.68 6.79 8.02
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 1.36 1.30 1.06 0.94 1.05 1.21 1.31 1.13
Accounts Receivable Turnover
0.00 5.71 6.11 5.72 5.65 6.38 6.67 6.70 5.72
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 38.76 36.86 32.15 32.51 41.90 55.82 64.13 48.46
Accounts Payable Turnover
0.00 12.35 14.10 13.76 13.31 16.34 19.07 23.73 21.54
Days Sales Outstanding (DSO)
0.00 63.90 59.75 63.80 64.65 57.23 54.76 54.50 63.80
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 29.56 25.88 26.53 27.43 22.34 19.14 15.38 16.95
Cash Conversion Cycle (CCC)
0.00 34.34 33.86 37.27 37.23 34.89 35.62 39.12 46.85
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 1,086 1,646 1,895 2,223 2,640 2,839 3,304 3,485
Invested Capital Turnover
0.00 6.56 2.90 2.21 1.78 1.73 1.99 2.20 1.88
Increase / (Decrease) in Invested Capital
0.00 1,086 560 249 328 417 199 465 180
Enterprise Value (EV)
0.00 2,553 4,114 3,749 3,764 5,384 7,129 10,684 7,423
Market Capitalization
500 500 4,098 3,667 3,441 4,787 6,578 9,796 6,581
Book Value per Share
$0.00 ($52.25) $16.42 $18.01 $18.59 $19.74 $21.81 $22.76 $24.81
Tangible Book Value per Share
$0.00 ($101.74) $3.25 $3.04 $2.74 $1.23 $2.09 ($0.15) $1.22
Total Capital
0.00 1,430 1,910 2,451 2,678 3,010 3,240 3,896 4,100
Total Debt
0.00 475 249 590 741 914 863 1,362 1,332
Total Long-Term Debt
0.00 475 249 540 741 855 863 898 1,332
Net Debt
0.00 130 -15 34 286 544 462 770 717
Capital Expenditures (CapEx)
26 29 64 32 20 30 40 49 67
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 201 187 219 258 408 454 557 685
Debt-free Net Working Capital (DFNWC)
0.00 483 382 706 602 671 727 1,010 1,152
Net Working Capital (NWC)
0.00 483 382 656 602 612 727 547 1,152
Net Nonoperating Expense (NNE)
15 -50 51 12 16 15 19 48 29
Net Nonoperating Obligations (NNO)
0.00 130 -15 34 286 544 462 770 717
Total Depreciation and Amortization (D&A)
28 63 127 133 147 124 123 107 122
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.66% 4.72% 5.58% 7.04% 9.73% 8.34% 8.25% 10.77%
Debt-free Net Working Capital to Revenue
0.00% 13.56% 9.66% 18.01% 16.43% 15.99% 13.35% 14.96% 18.10%
Net Working Capital to Revenue
0.00% 13.56% 9.66% 16.73% 16.43% 14.58% 13.35% 8.10% 18.10%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.30 $0.98 $0.62 $0.93 $1.53 $2.21 $2.26
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.30 $0.97 $0.59 $0.87 $1.42 $2.12 $2.20
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Normalized Net Operating Profit after Tax (NOPAT)
126 189 64 131 105 141 227 338 338
Normalized NOPAT Margin
4.19% 5.31% 1.63% 3.34% 2.86% 3.37% 4.17% 5.01% 5.30%
Pre Tax Income Margin
4.41% 7.30% 1.70% 4.12% 3.08% 3.96% 4.85% 5.45% 6.01%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
9.26 13.34 3.78 8.66 7.34 8.13 9.31 6.09 8.32
NOPAT to Interest Expense
8.00 9.07 7.91 6.25 5.91 6.10 7.21 4.84 6.58
EBIT Less CapEx to Interest Expense
7.64 11.95 1.09 7.11 6.22 6.84 8.05 5.39 7.01
NOPAT Less CapEx to Interest Expense
6.37 7.68 5.22 4.70 4.80 4.81 5.94 4.14 5.27
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
46.05% 7.89% 68.82% 4.89% 42.64% 19.06% 6.01% 10.05% 20.49%
Augmented Payout Ratio
46.05% 7.89% 73.40% 4.89% 67.04% 45.33% 11.30% 18.65% 60.96%

Quarterly Metrics And Ratios for Parsons

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 105,831,019.00 106,978,521.00 106,805,394.00
DEI Adjusted Shares Outstanding
- - - - - - - - 105,831,019.00 106,978,521.00 106,805,394.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.50 -0.14 0.51
Growth Metrics
- - - - - - - - - - -
Revenue Growth
30.87% 23.15% 27.60% 16.07% 1.22% -5.16% -10.41% -7.52% -4.07% -0.53% 1.78%
EBITDA Growth
56.09% 29.64% 25.15% 9.73% 28.22% -5.31% -1.47% 9.84% -4.93% -56.03% -1.40%
EBIT Growth
87.85% 45.89% 40.60% 21.83% 38.30% -10.36% -6.32% 7.57% -13.88% -80.55% -5.69%
NOPAT Growth
84.90% 45.78% 37.03% 23.67% 8.15% -13.29% -0.85% 5.70% -13.44% -100.21% -11.75%
Net Income Growth
-361.12% 47.38% 43.10% 272.86% 48.72% -12.67% -4.43% 7.83% -20.27% -100.66% -17.58%
EPS Growth
-539.13% 65.79% 54.76% 374.36% 62.16% -20.63% -9.23% 8.51% -18.33% -128.00% -13.56%
Operating Cash Flow Growth
-605.45% 601.72% 46.89% -33.33% 81.41% -0.88% -45.54% 32.15% 68.61% -63.97% 65.02%
Free Cash Flow Firm Growth
41.45% -0.01% 82.10% -183.95% 1.99% -207.24% -669.93% 74.81% -53.59% -41.34% -6.17%
Invested Capital Growth
13.98% 7.38% 4.62% 16.38% 12.29% 14.78% 13.72% 5.46% 15.10% 15.12% 12.34%
Revenue Q/Q Growth
2.77% 8.78% 8.36% -4.19% -10.38% 1.93% 2.36% -1.11% -7.02% 5.68% 4.74%
EBITDA Q/Q Growth
11.27% 8.52% 3.41% -12.12% 11.25% -6.33% 7.61% -2.04% -3.71% -56.68% 141.32%
EBIT Q/Q Growth
21.96% 14.01% 4.09% -15.82% 12.65% -9.19% 8.79% -3.34% -9.80% -79.50% 427.60%
NOPAT Q/Q Growth
14.56% 22.32% 4.39% -15.47% 15.21% -14.72% 19.37% -7.96% -7.62% -100.21% 49,799.24%
Net Income Q/Q Growth
-258.66% 187.63% 6.03% 152.92% -62.22% -13.81% 16.04% -8.56% -12.81% -100.71% 14,596.99%
EPS Q/Q Growth
-358.97% 162.38% 3.17% 184.62% -67.57% -16.67% 18.00% -13.56% -3.92% -128.57% 464.29%
Operating Cash Flow Q/Q Growth
-133.36% 354.22% 85.47% -57.61% -109.30% 1,455.74% 1.91% 2.87% -102.21% 1,656.32% 366.68%
Free Cash Flow Firm Q/Q Growth
-57.23% 60.51% 65.45% -826.63% 25.17% -28.26% 13.42% 69.81% -358.07% -18.03% 34.97%
Invested Capital Q/Q Growth
6.40% -1.65% -0.82% 9.87% 4.79% 0.52% -1.73% 1.88% 14.36% 0.54% -4.11%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.15% 21.04% 19.90% 21.32% 22.77% 21.99% 22.19% 23.03% 23.97% 18.74% 23.15%
EBITDA Margin
8.28% 8.26% 7.88% 7.23% 8.97% 8.25% 8.67% 8.59% 8.89% 3.65% 8.40%
Operating Margin
6.63% 6.67% 6.35% 5.76% 7.03% 6.04% 6.66% 6.56% 6.42% 0.08% 6.29%
EBIT Margin
6.42% 6.72% 6.46% 5.67% 7.13% 6.35% 6.75% 6.60% 6.40% 1.24% 6.26%
Profit (Net Income) Margin
-6.00% 4.83% 4.73% 12.48% 5.26% 4.45% 5.04% 4.66% 4.37% -0.03% 4.08%
Tax Burden Percent
74.08% 78.27% 79.17% 77.10% 81.17% 79.04% 83.61% 78.95% 80.21% -12.38% 76.73%
Interest Burden Percent
-126.22% 91.82% 92.47% 285.27% 90.89% 88.58% 89.32% 89.49% 85.14% 19.19% 85.06%
Effective Tax Rate
0.00% 21.73% 20.83% 22.90% 18.83% 20.96% 16.39% 21.05% 19.79% 112.38% 23.27%
Return on Invested Capital (ROIC)
9.31% 10.91% 11.13% 9.75% 11.80% 9.80% 11.25% 9.71% 8.71% -0.02% 8.40%
ROIC Less NNEP Spread (ROIC-NNEP)
-13.71% 9.95% 10.24% 32.40% 11.02% 9.14% 9.99% 8.60% 7.63% -0.05% 7.08%
Return on Net Nonoperating Assets (RNNOA)
-4.46% 2.97% 2.68% 8.13% 4.04% 2.91% 2.65% 2.41% 3.09% -0.02% 2.42%
Return on Equity (ROE)
4.86% 13.88% 13.81% 17.88% 15.84% 12.70% 13.90% 12.12% 11.80% -0.04% 10.82%
Cash Return on Invested Capital (CROIC)
-2.92% 3.67% 6.94% -4.12% -1.02% -3.50% -2.48% 4.63% -5.29% -7.45% -5.11%
Operating Return on Assets (OROA)
7.96% 8.44% 8.26% 7.44% 9.16% 7.75% 7.85% 7.46% 7.04% 1.32% 6.75%
Return on Assets (ROA)
-7.44% 6.07% 6.05% 16.37% 6.75% 5.43% 5.86% 5.27% 4.81% -0.03% 4.41%
Return on Common Equity (ROCE)
4.68% 13.35% 13.29% 17.12% 15.23% 12.17% 13.33% 11.56% 11.36% -0.03% 10.39%
Return on Equity Simple (ROE_SIMPLE)
3.75% 4.80% 5.72% 0.00% 12.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
71 87 91 77 89 76 90 83 77 -0.16 80
NOPAT Margin
4.64% 5.22% 5.03% 4.44% 5.70% 4.77% 5.57% 5.18% 5.15% -0.01% 4.83%
Net Nonoperating Expense Percent (NNEP)
23.02% 0.96% 0.89% -22.65% 0.78% 0.65% 1.26% 1.11% 1.07% 0.03% 1.32%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.98% 2.29% 1.87% 2.26% 2.03% 1.73% 0.00% 1.86%
Cost of Revenue to Revenue
78.85% 78.96% 80.10% 78.68% 77.23% 78.01% 77.81% 76.97% 76.03% 81.27% 76.85%
SG&A Expenses to Revenue
14.39% 13.37% 13.60% 15.26% 15.70% 15.91% 16.04% 16.20% 17.97% 16.51% 17.30%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.52% 14.37% 13.55% 14.22% 15.75% 15.95% 15.53% 16.47% 17.55% 18.65% 16.86%
Earnings before Interest and Taxes (EBIT)
99 112 117 98 111 101 110 106 95 20 103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
127 138 143 125 139 131 141 138 133 57 139
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.05 5.41 4.76 4.05 2.58 3.05 3.46 2.49 2.16 2.13 1.66
Price to Tangible Book Value (P/TBV)
90.28 66.87 150.11 0.00 894.62 0.00 161.20 50.82 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.50 1.96 1.69 1.45 0.93 1.15 1.36 1.03 0.91 0.89 0.69
Price to Earnings (P/E)
308.08 221.62 139.93 41.68 24.18 30.98 36.94 27.29 25.16 35.60 29.68
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.32% 0.45% 0.71% 2.40% 4.14% 3.23% 2.71% 3.66% 3.97% 2.81% 3.37%
Enterprise Value to Invested Capital (EV/IC)
3.12 4.23 3.89 3.23 2.12 2.48 2.84 2.13 1.77 1.73 1.44
Enterprise Value to Revenue (EV/Rev)
1.66 2.10 1.80 1.58 1.08 1.29 1.50 1.17 1.12 1.10 0.88
Enterprise Value to EBITDA (EV/EBITDA)
20.86 25.98 22.42 20.04 13.00 15.51 17.53 13.53 13.05 14.81 11.89
Enterprise Value to EBIT (EV/EBIT)
28.38 34.21 28.65 25.07 16.05 19.39 22.19 17.39 17.17 20.99 17.10
Enterprise Value to NOPAT (EV/NOPAT)
32.79 40.58 34.72 31.57 21.22 25.86 29.17 21.99 21.70 28.05 23.43
Enterprise Value to Operating Cash Flow (EV/OCF)
27.27 26.08 19.94 20.40 12.74 15.05 22.21 15.52 14.53 18.05 11.31
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 119.26 57.31 0.00 0.00 0.00 0.00 47.24 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.63 0.60 0.56 0.54 0.52 0.54 0.50 0.48 0.61 0.59 0.56
Long-Term Debt to Equity
0.60 0.58 0.51 0.35 0.35 0.51 0.50 0.48 0.59 0.58 0.54
Financial Leverage
0.32 0.30 0.26 0.25 0.37 0.32 0.27 0.28 0.41 0.39 0.34
Leverage Ratio
2.14 2.16 2.18 2.10 2.20 2.22 2.20 2.12 2.16 2.20 2.17
Compound Leverage Factor
-2.70 1.98 2.02 5.98 2.00 1.96 1.97 1.90 1.84 0.42 1.84
Debt to Total Capital
38.57% 37.61% 35.80% 34.95% 34.29% 35.15% 33.37% 32.49% 37.85% 37.30% 35.75%
Short-Term Debt to Total Capital
1.51% 1.42% 3.07% 11.89% 11.23% 2.10% 0.00% 0.00% 0.97% 0.92% 0.91%
Long-Term Debt to Total Capital
37.06% 36.19% 32.73% 23.06% 23.06% 33.05% 33.37% 32.49% 36.88% 36.38% 34.84%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.56% 2.72% 2.71% 3.03% 2.37% 2.62% 2.67% 3.07% 2.36% 2.65% 2.58%
Common Equity to Total Capital
58.87% 59.67% 61.49% 62.02% 63.34% 62.24% 63.96% 64.45% 59.80% 60.04% 61.67%
Debt to EBITDA
3.05 2.83 2.58 2.55 2.36 2.55 2.41 2.43 3.10 3.49 3.28
Net Debt to EBITDA
1.82 1.44 1.14 1.44 1.63 1.54 1.36 1.31 2.27 2.59 2.27
Long-Term Debt to EBITDA
2.93 2.73 2.36 1.69 1.58 2.40 2.41 2.43 3.02 3.40 3.20
Debt to NOPAT
4.79 4.43 3.99 4.02 3.84 4.25 4.01 3.95 5.15 6.61 6.46
Net Debt to NOPAT
2.86 2.26 1.76 2.27 2.65 2.57 2.27 2.12 3.78 4.91 4.47
Long-Term Debt to NOPAT
4.61 4.26 3.65 2.65 2.59 4.00 4.01 3.95 5.02 6.45 6.30
Altman Z-Score
3.31 4.01 3.71 3.51 2.86 3.05 3.29 2.88 2.54 2.41 2.29
Noncontrolling Interest Sharing Ratio
3.55% 3.82% 3.80% 4.23% 3.87% 4.19% 4.11% 4.60% 3.71% 4.14% 4.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.79 1.80 1.55 1.29 1.29 1.61 1.67 1.75 1.75 1.66 1.59
Quick Ratio
1.07 1.10 0.97 0.81 0.75 0.98 1.04 1.04 0.93 0.86 0.87
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-307 -121 -42 -388 -290 -372 -322 -97 -446 -526 -342
Operating Cash Flow to CapEx
-672.25% 1,750.37% 2,561.75% 677.31% -87.49% 1,699.83% 1,241.14% 538.07% -24.80% 356.96% 1,500.64%
Free Cash Flow to Firm to Interest Expense
-1.37 -9.32 -3.21 0.00 -23.71 -29.63 -23.82 -7.52 -27.88 -32.13 -21.00
Operating Cash Flow to Interest Expense
-0.28 12.39 22.94 0.00 -0.96 12.71 12.03 12.93 -0.23 3.51 16.49
Operating Cash Flow Less CapEx to Interest Expense
-0.33 11.69 22.05 0.00 -2.06 11.97 11.06 10.53 -1.16 2.53 15.39
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.24 1.26 1.28 1.31 1.28 1.22 1.16 1.13 1.10 1.06 1.08
Accounts Receivable Turnover
6.50 6.14 6.71 6.70 6.30 6.05 5.75 5.72 5.67 5.44 5.42
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
60.07 63.25 64.93 64.13 61.47 60.49 57.21 48.46 45.60 44.59 42.98
Accounts Payable Turnover
18.74 19.51 18.03 23.73 18.96 19.40 17.71 21.54 18.68 18.35 19.10
Days Sales Outstanding (DSO)
56.19 59.43 54.43 54.50 57.92 60.37 63.47 63.80 64.34 67.11 67.33
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
19.48 18.71 20.25 15.38 19.25 18.81 20.61 16.95 19.54 19.90 19.11
Cash Conversion Cycle (CCC)
36.71 40.72 34.18 39.12 38.67 41.56 42.87 46.85 44.80 47.22 48.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,083 3,032 3,007 3,304 3,462 3,480 3,420 3,485 3,985 4,007 3,842
Invested Capital Turnover
2.01 2.09 2.21 2.20 2.07 2.05 2.02 1.88 1.69 1.68 1.74
Increase / (Decrease) in Invested Capital
378 208 133 465 379 448 413 180 523 526 422
Enterprise Value (EV)
9,634 12,819 11,704 10,684 7,331 8,635 9,718 7,423 7,068 6,936 5,544
Market Capitalization
8,701 12,005 11,009 9,796 6,322 7,670 8,855 6,581 5,733 5,605 4,376
Book Value per Share
$14.65 $15.12 $21.78 $22.76 $22.98 $23.54 $23.95 $24.81 $25.04 $24.60 $24.70
Tangible Book Value per Share
$0.66 $1.22 $0.69 ($0.15) $0.07 ($0.07) $0.51 $1.22 ($1.72) ($1.63) ($1.37)
Total Capital
3,651 3,718 3,761 3,896 3,874 4,042 3,999 4,100 4,431 4,382 4,277
Total Debt
1,408 1,398 1,346 1,362 1,328 1,421 1,334 1,332 1,677 1,635 1,529
Total Long-Term Debt
1,353 1,345 1,231 898 894 1,336 1,334 1,332 1,634 1,594 1,490
Net Debt
840 713 593 770 916 859 755 717 1,231 1,215 1,057
Capital Expenditures (CapEx)
9.43 9.21 12 19 13 9.40 13 31 15 16 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
705 671 462 557 701 660 639 685 873 857 704
Debt-free Net Working Capital (DFNWC)
1,129 1,200 1,021 1,010 971 1,071 1,061 1,152 1,157 1,123 1,001
Net Working Capital (NWC)
1,074 1,147 905 547 536 986 1,061 1,152 1,115 1,083 962
Net Nonoperating Expense (NNE)
163 6.49 5.45 -140 6.87 5.12 8.47 8.28 12 0.30 12
Net Nonoperating Obligations (NNO)
840 713 593 770 916 859 755 717 1,231 1,259 1,094
Total Depreciation and Amortization (D&A)
29 26 26 27 29 30 31 32 37 38 35
Debt-free, Cash-free Net Working Capital to Revenue
12.15% 10.97% 7.09% 8.25% 10.35% 9.87% 9.83% 10.77% 13.86% 13.63% 11.13%
Debt-free Net Working Capital to Revenue
19.44% 19.60% 15.68% 14.96% 14.34% 16.03% 16.34% 18.10% 18.37% 17.85% 15.83%
Net Working Capital to Revenue
18.49% 18.74% 13.90% 8.10% 7.91% 14.76% 16.34% 18.10% 17.69% 17.21% 15.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.01) $0.65 $0.68 $1.89 $0.62 $0.52 $0.60 $0.52 $0.49 ($0.14) $0.51
Adjusted Weighted Average Basic Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M
Adjusted Diluted Earnings per Share
($1.01) $0.63 $0.65 $1.85 $0.60 $0.50 $0.59 $0.51 $0.49 ($0.14) $0.51
Adjusted Weighted Average Diluted Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M 106.81M 105.54M
Normalized Net Operating Profit after Tax (NOPAT)
71 87 91 77 89 76 90 83 77 0.91 80
Normalized NOPAT Margin
4.64% 5.22% 5.03% 4.44% 5.70% 4.77% 5.57% 5.18% 5.15% 0.06% 4.83%
Pre Tax Income Margin
-8.10% 6.17% 5.97% 16.19% 6.48% 5.63% 6.03% 5.91% 5.45% 0.24% 5.32%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.44 8.63 8.97 0.00 9.05 8.01 8.09 8.17 5.97 1.19 6.34
NOPAT to Interest Expense
0.32 6.70 6.98 0.00 7.24 6.02 6.67 6.41 4.80 -0.01 4.89
EBIT Less CapEx to Interest Expense
0.40 7.93 8.07 0.00 7.95 7.26 7.12 5.77 5.04 0.21 5.24
NOPAT Less CapEx to Interest Expense
0.28 6.00 6.09 0.00 6.14 5.27 5.70 4.01 3.86 -0.99 3.79
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
28.71% 23.72% 22.19% 10.05% 18.88% 19.21% 20.77% 20.49% 18.78% 24.76% 27.25%
Augmented Payout Ratio
34.92% 35.93% 32.02% 18.65% 34.63% 37.11% 47.13% 60.96% 64.96% 85.75% 109.39%

Financials Breakdown Chart

Key Financial Trends

Parsons (NYSE: PSN) has delivered strong revenue growth over the longer term, but its latest results show a sharp deterioration in profitability and cash conversion. Revenue increased from $1.10 billion in Q4 2022 to $1.58 billion in Q2 2026. However, growth has recently stalled: Q2 2026 revenue was down slightly from $1.58 billion in Q2 2025 and below the $1.60 billion reported in Q4 2025.

The biggest concern is margin compression. Q2 2026 gross profit fell to $295.2 million, producing an 18.7% gross margin versus approximately 22.0% in Q1 2026 and Q2 2025. Operating income plunged to just $1.3 million, compared with $95.7 million in Q1 2026 and $95.6 million in Q2 2025. Higher other operating expenses, which reached $33.7 million in the latest quarter, were a major contributor.

Parsons reported a $465,000 consolidated net loss in Q2 2026 and a $15.2 million loss attributable to common shareholders, or negative $0.14 per diluted share. This compares with common-shareholder earnings of $52.9 million, or $0.49 per share, in Q1 2026 and $55.2 million, or $0.50 per share, in Q2 2025. The latest quarter marks a significant reversal from the generally profitable results recorded throughout 2023, 2024 and 2025.

Cash flow was better than the income statement suggested, but it also weakened compared with prior-year levels. Operating cash flow was $57.6 million in Q2 2026, an improvement from the $3.7 million outflow in Q1, but well below the $159.8 million generated in Q2 2025 and the $161.2 million generated in Q2 2024. The company also spent $29.8 million on acquisitions and $16.1 million on capital expenditures during the latest quarter.

The balance sheet provides some liquidity support, although leverage remains elevated. Cash and equivalents declined to $266.0 million from $283.9 million in Q1 and $411.3 million a year earlier. Total current assets increased to $2.72 billion, while current liabilities reached $1.64 billion, implying a current ratio of roughly 1.7. Total debt, including short-term debt, long-term debt and capital lease obligations, was approximately $1.64 billion at June 30, 2026.

  • Long-term revenue growth remains evident: Quarterly revenue rose from $1.10 billion in Q4 2022 to $1.58 billion in Q2 2026, supported in part by acquisitions and business expansion.
  • Operating cash flow remained positive in Q2 2026: Parsons generated $57.6 million from operations after producing a $3.7 million outflow in Q1, showing some improvement in near-term cash generation.
  • Liquidity remains adequate: Current assets of $2.72 billion exceeded current liabilities of $1.64 billion, providing a cushion for working-capital needs and near-term obligations.
  • Acquisition activity has expanded the asset base: Goodwill increased to $2.42 billion from $1.79 billion in Q2 2024, while total assets grew to $6.11 billion from $5.24 billion over the same period.
  • Share repurchases have partially offset dilution: Parsons repurchased $15.0 million of common stock in Q2 2026, and weighted-average shares declined from 107.0 million in Q1 to 106.8 million in Q2. However, the share count remains above Q2 2023 levels.
  • Working capital helped latest-quarter cash flow: Changes in operating assets and liabilities provided $30.3 million in Q2 2026, but this benefit may not be recurring and accounts receivable increased to $1.15 billion.
  • Profitability deteriorated sharply: Operating income fell to $1.3 million in Q2 2026 from more than $95 million in both Q1 2026 and Q2 2025, while the operating margin approached breakeven.
  • Gross margins have compressed: The Q2 2026 gross margin of approximately 18.7% was materially below the roughly 22% margins recorded in Q1 2026 and Q2 2025, suggesting cost pressure or an unfavorable project mix.
  • Common-shareholder earnings turned negative: Parsons reported a $15.2 million loss attributable to common shareholders in Q2 2026, compared with $52.9 million of earnings in the preceding quarter and $55.2 million a year earlier.
  • Cash balances and leverage are moving in unfavorable directions: Cash declined by approximately $145 million year over year, while total debt and lease obligations increased to roughly $1.64 billion from approximately $1.42 billion in Q2 2025.

Overall, Parsons’ financial profile is mixed. The company has grown substantially and retains positive operating cash flow and reasonable short-term liquidity. However, the latest quarter raises concerns about project profitability, cost control, debt levels and the sustainability of earnings. Investors may want to monitor whether margins recover in coming quarters and whether Parsons can continue reducing debt without sacrificing investment in growth.

11/18/26 10:04 AM ETAI Generated. May Contain Errors.

Parsons Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Parsons' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Parsons' net income appears to be on an upward trend, with a most recent value of $308.86 million in 2025, rising from $111.54 million in 2017. The previous period was $290.67 million in 2024. See Parsons' forecast for analyst expectations on what's next for the company.

Parsons' total operating income in 2025 was $418.07 million, based on the following breakdown:
  • Total Gross Profit: $1.43 billion
  • Total Operating Expenses: $1.01 billion

Over the last 8 years, Parsons' total revenue changed from $3.02 billion in 2017 to $6.36 billion in 2025, a change of 110.9%.

In the past 13 quarters, Parsons' cash and equivalents has ranged from $178.59 million in Q2 2023 to $558.82 million in Q3 2024, and is currently $296.95 million as of their latest financial filing in Q3 2026.

Parsons had total debt of $1.33 billion at the end of 2025, a 2.2% decrease from 2024, and none in 2017.

Over the last 8 years, Parsons' book value per share changed from 0.00 in 2017 to 24.81 in 2025, a change of 2,481.0%.



Financial statements for NYSE:PSN last updated on 10/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners